{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:09:19Z","timestamp":1777392559764,"version":"3.51.4"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100018543","name":"Natural Science Foundation of Tibet Autonomous Region","doi-asserted-by":"publisher","award":["XZ2021ZR-ZY12(Z)"],"award-info":[{"award-number":["XZ2021ZR-ZY12(Z)"]}],"id":[{"id":"10.13039\/501100018543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103470"],"award-info":[{"award-number":["82103470"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772916"],"award-info":[{"award-number":["81772916"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20171132"],"award-info":[{"award-number":["BK20171132"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3601800"],"award-info":[{"award-number":["2022YFC3601800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-025-02597-4","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T06:44:26Z","timestamp":1748933066000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["TNF\u03b1 activation of the PLEKHA5-FCRLA axis disturbs lipid metabolism, leading to the progression of cutaneous malignant melanoma"],"prefix":"10.1186","volume":"24","author":[{"given":"Kexin","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqi","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinliang","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiulian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"issue":"4","key":"2597_CR1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1615\/CritRevEukaryotGeneExpr.2020028454","volume":"30","author":"B Ahmed","year":"2020","unstructured":"Ahmed B, Qadir MI, Ghafoor S. Malignant melanoma: skin Cancer-Diagnosis, prevention, and treatment. Crit Rev Eukaryot Gene Expr. 2020;30(4):291\u20137.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"8","key":"2597_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11864-019-0666-x","volume":"20","author":"M Wada-Ohno","year":"2019","unstructured":"Wada-Ohno M, Ito T, Furue M. Adjuvant therapy for melanoma. Curr Treat Options Oncol. 2019;20(8):63.","journal-title":"Curr Treat Options Oncol"},{"issue":"10304","key":"2597_CR3","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S0140-6736(21)01206-X","volume":"398","author":"MS Carlino","year":"2021","unstructured":"Carlino MS, Larkin J, Long GV. Immune checkpoint inhibitors in melanoma. Lancet. 2021;398(10304):1002\u201314.","journal-title":"Lancet"},{"issue":"11","key":"2597_CR4","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nrc.2016.89","volume":"16","author":"F R\u00f6hrig","year":"2016","unstructured":"R\u00f6hrig F, Schulze A. The multifaceted roles of fatty acid synthesis in cancer. Nat Rev Cancer. 2016;16(11):732\u201349.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"2597_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrc3038","volume":"11","author":"WH Koppenol","year":"2011","unstructured":"Koppenol WH, Bounds PL, Dang CV. Otto Warburg\u2019s contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011;11(5):325\u201337.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"2597_CR6","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.ccr.2006.05.012","volume":"9","author":"T Bui","year":"2006","unstructured":"Bui T, Thompson CB. Cancer\u2019s sweet tooth. Cancer Cell. 2006;9(6):419\u201320.","journal-title":"Cancer Cell"},{"issue":"7503","key":"2597_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nature13474","volume":"510","author":"JC Holthuis","year":"2014","unstructured":"Holthuis JC, Menon AK. Lipid landscapes and pipelines in membrane homeostasis. Nature. 2014;510(7503):48\u201357.","journal-title":"Nature"},{"issue":"1","key":"2597_CR8","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1038\/oncsis.2015.49","volume":"5","author":"S Beloribi-Djefaflia","year":"2016","unstructured":"Beloribi-Djefaflia S, Vasseur S, Guillaumond F. Lipid metabolic reprogramming in cancer cells. Oncogenesis. 2016;5(1):e189.","journal-title":"Oncogenesis"},{"issue":"1","key":"2597_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1034\/j.1600-0560.2003.300104.x","volume":"30","author":"D Innocenzi","year":"2003","unstructured":"Innocenzi D, Al\u00f2 PL, Balzani A, et al. Fatty acid synthase expression in melanoma. J Cutan Pathol. 2003;30(1):23\u20138.","journal-title":"J Cutan Pathol"},{"issue":"12","key":"2597_CR10","doi-asserted-by":"publisher","first-page":"110995","DOI":"10.1016\/j.celrep.2022.110995","volume":"39","author":"DJ Wilcock","year":"2022","unstructured":"Wilcock DJ, Badrock AP, Wong CW, et al. Oxidative stress from DGAT1 oncoprotein Inhibition in melanoma suppresses tumor growth when ROS defenses are also breached. Cell Rep. 2022;39(12):110995.","journal-title":"Cell Rep"},{"issue":"1","key":"2597_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13046-023-02664-7","volume":"42","author":"A Talebi","year":"2023","unstructured":"Talebi A, de Laat V, Spotbeen X, et al. Pharmacological induction of membrane lipid poly-unsaturation sensitizes melanoma to ROS inducers and overcomes acquired resistance to targeted therapy. J Exp Clin Cancer Res. 2023;42(1):92.","journal-title":"J Exp Clin Cancer Res"},{"key":"2597_CR12","doi-asserted-by":"crossref","unstructured":"Pellerin L, Carri\u00e9 L, Dufau C et al. Lipid metabolic reprogramming: role in melanoma progression and therapeutic perspectives. Cancers (Basel). 2020. 12(11):3147.","DOI":"10.3390\/cancers12113147"},{"key":"2597_CR13","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3389\/fonc.2013.00184","volume":"3","author":"AJ Trevarton","year":"2013","unstructured":"Trevarton AJ, Mann MB, Knapp C, et al. MelanomaDB: A web tool for integrative analysis of melanoma genomic information to identify Disease-Associated molecular pathways. Front Oncol. 2013;3:184.","journal-title":"Front Oncol"},{"key":"2597_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.canlet.2018.11.019","volume":"443","author":"B Xie","year":"2019","unstructured":"Xie B, Wang S, Jiang N, Li JJ. Cyclin B1\/CDK1-regulated mitochondrial bioenergetics in cell cycle progression and tumor resistance. Cancer Lett. 2019;443:56\u201366.","journal-title":"Cancer Lett"},{"key":"2597_CR15","doi-asserted-by":"publisher","first-page":"240","DOI":"10.2174\/1568009620666200115162814","volume":"20","author":"M Cardano","year":"2020","unstructured":"Cardano M, Tribioli C, Prosperi E. Targeting proliferating cell nuclear antigen (PCNA) as an effective strategy to inhibit tumor cell proliferation. Curr Cancer Drug Targets. 2020;20:240\u201352.","journal-title":"Curr Cancer Drug Targets"},{"key":"2597_CR16","doi-asserted-by":"publisher","first-page":"5492","DOI":"10.18632\/oncotarget.23695","volume":"9","author":"C Gao","year":"2018","unstructured":"Gao C, Wang Y, Broaddus R, Sun L, Xue F, Zhang W. Exon 3 mutations of CTNNB1 drive tumorigenesis: a review. Oncotarget. 2018;9:5492\u2013508.","journal-title":"Oncotarget"},{"key":"2597_CR17","doi-asserted-by":"publisher","first-page":"941565","DOI":"10.3389\/fgene.2022.941565","volume":"13","author":"C Greil","year":"2022","unstructured":"Greil C, Engelhardt M, W\u00e4sch R. The role of the APC\/C and its coactivators Cdh1 and Cdc20 in Cancer development and therapy. Front Genet. 2022;13:941565.","journal-title":"Front Genet"},{"key":"2597_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/PAI.0000000000000908","volume":"29","author":"R Fulton","year":"2021","unstructured":"Fulton R. Getting a grip on Ki-67. Appl Immunohistochem Mol Morphol. 2021;29:83\u20135.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"2597_CR19","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1101\/gad.349358.122","volume":"36","author":"KM Ridge","year":"2022","unstructured":"Ridge KM, Eriksson JE, Pekny M, Goldman RD. Roles of vimentin in health and disease. Genes Dev. 2022;36:391\u2013407.","journal-title":"Genes Dev"},{"key":"2597_CR20","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1007\/s00018-014-1582-7","volume":"71","author":"G Neumayer","year":"2014","unstructured":"Neumayer G, Belzil C, Gruss OJ, Nguyen MD. TPX2: of spindle assembly, DNA damage response, and cancer. Cell Mol Life Sci. 2014;71:3027\u201347.","journal-title":"Cell Mol Life Sci"},{"key":"2597_CR21","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1083\/jcb.2155if","volume":"215","author":"B Short","year":"2016","unstructured":"Short B. GTSE1 leads cancer cells into CIN. J Cell Biol. 2016;215:593.","journal-title":"J Cell Biol"},{"key":"2597_CR22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/ijc.20735","volume":"114","author":"T Inozume","year":"2005","unstructured":"Inozume T, Matsuzaki Y, Kurihara S, Fujita T, Yamamoto A, Aburatani H, Shimada S, Kawakami Y. Novel melanoma antigen, FCRL\/FREB, identified by cDNA profile comparison using DNA chip are Immunogenic in multiple melanoma patients. Int J Cancer. 2005;114:283\u201390.","journal-title":"Int J Cancer"},{"key":"2597_CR23","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41571-021-00588-9","volume":"19","author":"DJ Propper","year":"2022","unstructured":"Propper DJ, Balkwill FR. Harnessing cytokines and chemokines for cancer therapy. Nat Rev Clin Oncol. 2022;19:237\u201353.","journal-title":"Nat Rev Clin Oncol"},{"key":"2597_CR24","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.coph.2004.04.004","volume":"4","author":"GM Anderson","year":"2004","unstructured":"Anderson GM, Nakada MT, DeWitte M. Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer. Curr Opin Pharmacol. 2004;4:314\u201320.","journal-title":"Curr Opin Pharmacol"},{"key":"2597_CR25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.12659\/MSMBR.903910","volume":"23","author":"D Tang","year":"2017","unstructured":"Tang D, Tao D, Fang Y, Deng C, Xu Q, Zhou J. TNF-Alpha promotes invasion and metastasis via NF-Kappa B pathway in oral squamous cell carcinoma. Med Sci Monit Basic Res. 2017;23:141\u20139.","journal-title":"Med Sci Monit Basic Res"},{"key":"2597_CR26","doi-asserted-by":"publisher","first-page":"6139","DOI":"10.1038\/s41388-020-01432-7","volume":"39","author":"Q Wei","year":"2020","unstructured":"Wei Q, Qian Y, Yu J, Wong CC. Metabolic rewiring in the promotion of cancer metastasis: mechanisms and therapeutic implications. Oncogene. 2020;39:6139\u201356.","journal-title":"Oncogene"},{"key":"2597_CR27","doi-asserted-by":"publisher","first-page":"722","DOI":"10.3389\/fonc.2020.00722","volume":"10","author":"A Avagliano","year":"2020","unstructured":"Avagliano A, Fiume G, Pelagalli A, et al. Metabolic plasticity of melanoma cells and their crosstalk with tumor microenvironment. Front Oncol. 2020;10:722.","journal-title":"Front Oncol"},{"issue":"1","key":"2597_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/pcmr.12661","volume":"31","author":"GM Fischer","year":"2018","unstructured":"Fischer GM, Vashisht Gopal YN, McQuade JL, Peng W, DeBerardinis RJ, Davies MA. Metabolic strategies of melanoma cells: mechanisms, interactions with the tumor microenvironment, and therapeutic implications. Pigment Cell Melanoma Res. 2018;31(1):11\u201330.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"9","key":"2597_CR29","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1158\/2159-8290.CD-20-0329","volume":"10","author":"GM Alicea","year":"2020","unstructured":"Alicea GM, Rebecca VW, Goldman AR, et al. Changes in aged fibroblast lipid metabolism induce Age-Dependent melanoma cell resistance to targeted therapy via the fatty acid transporter FATP2. Cancer Discov. 2020;10(9):1282\u201395.","journal-title":"Cancer Discov"},{"issue":"11","key":"2597_CR30","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1002\/ijc.23835","volume":"123","author":"MA Carvalho","year":"2008","unstructured":"Carvalho MA, Zecchin KG, Seguin F, et al. Fatty acid synthase Inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model. Int J Cancer. 2008;123(11):2557\u201365.","journal-title":"Int J Cancer"},{"issue":"1","key":"2597_CR31","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.molcel.2019.10.014","volume":"77","author":"Y Vivas-Garc\u00eda","year":"2020","unstructured":"Vivas-Garc\u00eda Y, Falletta P, Liebing J, et al. Lineage-Restricted regulation of SCD and fatty acid saturation by MITF controls melanoma phenotypic plasticity. Mol Cell. 2020;77(1):120\u2013e1379.","journal-title":"Mol Cell"},{"issue":"1","key":"2597_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cell.2009.11.027","volume":"140","author":"DK Nomura","year":"2010","unstructured":"Nomura DK, Long JZ, Niessen S, Hoover HS, Ng SW, Cravatt BF. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell. 2010;140(1):49\u201361.","journal-title":"Cell"},{"issue":"4","key":"2597_CR33","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3892\/ijmm.2014.1882","volume":"34","author":"A Ishitsuka","year":"2014","unstructured":"Ishitsuka A, Fujine E, Mizutani Y, et al. FTY720 and cisplatin synergistically induce the death of cisplatin-resistant melanoma cells through the downregulation of the PI3K pathway and the decrease in epidermal growth factor receptor expression. Int J Mol Med. 2014;34(4):1169\u201374.","journal-title":"Int J Mol Med"},{"issue":"3","key":"2597_CR34","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.bbrc.2012.04.012","volume":"421","author":"C Ji","year":"2012","unstructured":"Ji C, Yang YL, He L, et al. Increasing ceramides sensitizes genistein-induced melanoma cell apoptosis and growth Inhibition. Biochem Biophys Res Commun. 2012;421(3):462\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2597_CR35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/CMR.0b013e3282f60097","volume":"18","author":"A Saito","year":"2008","unstructured":"Saito A, Saito N, Mol W, et al. Simvastatin inhibits growth via apoptosis and the induction of cell cycle arrest in human melanoma cells. Melanoma Res. 2008;18(2):85\u201394.","journal-title":"Melanoma Res"},{"issue":"7","key":"2597_CR36","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1158\/1535-7163.MCT-13-0867","volume":"13","author":"R Gowda","year":"2014","unstructured":"Gowda R, Madhunapantula SV, Kuzu OF, Sharma A, Robertson GP. Targeting multiple key signaling pathways in melanoma using Leelamine. Mol Cancer Ther. 2014;13(7):1679\u201389.","journal-title":"Mol Cancer Ther"},{"issue":"8","key":"2597_CR37","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1158\/2326-6066.CIR-16-0400","volume":"5","author":"M Hennequart","year":"2017","unstructured":"Hennequart M, Pilotte L, Cane S, et al. Constitutive IDO1 expression in human tumors is driven by Cyclooxygenase-2 and mediates intrinsic immune resistance. Cancer Immunol Res. 2017;5(8):695\u2013709.","journal-title":"Cancer Immunol Res"},{"key":"2597_CR38","doi-asserted-by":"crossref","unstructured":"Fagerberg L, Hallstr\u00f6m BM, Oksvold P, Kampf C, Djureinovic D, Odeberg J, Habuka M, Tahmasebpoor S, Danielsson A, Edlund K, Asplund A, Sj\u00f6stedt E, Lundberg E, Szigyarto CA, Skogs M, Takanen JO, Berling H, Tegel H, Mulder J, Nilsson P, Schwenk JM, Lindskog C, Danielsson F, Mardinoglu A, Sivertsson A, von Feilitzen K, Forsberg M, Zwahlen M, Olsson I, Navani S, Huss M, Nielsen J, Ponten F, Uhl\u00e9n M. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Volume 13. MOLECULAR & CELLULAR PROTEOMICS; 2014. pp. 397\u2013406.","DOI":"10.1074\/mcp.M113.035600"},{"key":"2597_CR39","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/sj.embor.7401151","volume":"9","author":"N Yadav","year":"2008","unstructured":"Yadav N, Cheng D, Richard S, Morel M, Iyer VR, Aldaz CM, Bedford MT. CARM1 promotes adipocyte differentiation by coactivating PPARgamma. EMBO Rep. 2008;9:193\u20138.","journal-title":"EMBO Rep"},{"key":"2597_CR40","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/ncb3630","volume":"19","author":"F Liu","year":"2017","unstructured":"Liu F, Ma F, Wang Y, Hao L, Zeng H, Jia C, Wang Y, Liu P, Ong IM, Li B, Chen G, Jiang J, Gong S, Li L, Xu W. PKM2 methylation by CARM1 activates aerobic Glycolysis to promote tumorigenesis. Nat Cell Biol. 2017;19:1358\u201370.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"2597_CR41","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1476-4598-12-40","volume":"12","author":"MB Davis","year":"2013","unstructured":"Davis MB, Liu X, Wang S, Reeves J, Khramtsov A, Huo D, Olopade OI. Expression and sub-cellular localization of an epigenetic regulator, co-activator arginine methyltransferase 1 (CARM1), is associated with specific breast cancer subtypes and ethnicity. Mol Cancer. 2013;12(1):40. https:\/\/doi.org\/10.1186\/1476-4598-12-40.","journal-title":"Mol Cancer"},{"issue":"6","key":"2597_CR42","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.ejca.2012.11.026","volume":"49","author":"K Limm","year":"2013","unstructured":"Limm K, Ott C, Wallner S, Mueller DW, Oefner P, Hellerbrand C, Bosserhoff AK. Deregulation of protein methylation in melanoma. Eur J Cancer. 2013;49(6):1305\u201313. https:\/\/doi.org\/10.1016\/j.ejca.2012.11.026.","journal-title":"Eur J Cancer"},{"key":"2597_CR43","doi-asserted-by":"publisher","unstructured":"Wang Y, Song H, Miao Q, Wang Y, Qi J, Xu X, Sun J. PLA2G6 Silencing suppresses melanoma progression and affects ferroptosis revealed by quantitative proteomics. Front Oncol. 2022;12819235. https:\/\/doi.org\/10.3389\/fonc.2022.819235.","DOI":"10.3389\/fonc.2022.819235"},{"issue":"5","key":"2597_CR44","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1375\/twin.14.5.422","volume":"14","author":"M Kvaskoff","year":"2011","unstructured":"Kvaskoff M, Whiteman DC, Zhao ZZ, Montgomery GW, Martin NG, Hayward NK, Duffy DL. Polymorphisms in nevus-associated genes MTAP, PLA2G6, and IRF4 and the risk of invasive cutaneous melanoma. Twin Res Hum Genet. 2011;14(5):422\u201332. https:\/\/doi.org\/10.1375\/twin.14.5.422.","journal-title":"Twin Res Hum Genet"},{"issue":"11","key":"2597_CR45","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1016\/j.molcel.2022.03.026","volume":"82","author":"X Gao","year":"2022","unstructured":"Gao X, Liu Y, Li Y, Fan H, Wu R, Zhang R, Faubert B, He YY, Bissonnette MB, Xia S, Chen D, Mao H, Boggon TJ, Chen J. Lyso-PAF, a biologically inactive phospholipid, contributes to RAF1 activation. Mol Cell. 2022;82(11):1992\u2013e20059. https:\/\/doi.org\/10.1016\/j.molcel.2022.03.026.","journal-title":"Mol Cell"},{"key":"2597_CR46","doi-asserted-by":"publisher","first-page":"41077","DOI":"10.18632\/oncotarget.6218","volume":"6","author":"X Zhou","year":"2015","unstructured":"Zhou X, Wei J, Chen F, Xiao X, Huang T, He Q, Wang S, Du C, Mo Y, Lin L, Xie Y, Wei L, Lan Y, Murata M, Huang G, Ernberg I, Matskova L, Zhang Z. Epigenetic downregulation of the ISG15-conjugating enzyme UbcH8 impairs lipolysis and correlates with poor prognosis in nasopharyngeal carcinoma. Oncotarget. 2015;6:41077\u201391.","journal-title":"Oncotarget"},{"key":"2597_CR47","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.2174\/1389450117666160201114752","volume":"17","author":"A Nicolini","year":"2016","unstructured":"Nicolini A, Carpi A, Ferrari P, Biava PM, Rossi G. Immunotherapy and Hormone-therapy in metastatic breast cancer: A review and an update. Curr Drug Targets. 2016;17:1127\u201339.","journal-title":"Curr Drug Targets"},{"issue":"Pt 1","key":"2597_CR48","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1042\/0264-6021:3510019","volume":"351","author":"S Dowler","year":"2000","unstructured":"Dowler S, Currie RA, Campbell DG, Deak M, Kular G, Downes CP, Alessi DR. Identification of pleckstrin-homology-domain-containing proteins with novel phosphoinositide-binding specificities. Biochem J. 2000;351(Pt 1):19\u201331. https:\/\/doi.org\/10.1042\/0264-6021:3510019.","journal-title":"Biochem J"},{"issue":"3","key":"2597_CR49","doi-asserted-by":"publisher","first-page":"127","DOI":"10.32604\/biocell.2012.36.127","volume":"36","author":"Y Zou","year":"2012","unstructured":"Zou Y, Zhong W. A likely role for a novel PH-domain containing protein, PEPP2, in connecting membrane and cytoskeleton. Biocell. 2012;36(3):127\u201332.","journal-title":"Biocell"},{"issue":"1","key":"2597_CR50","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.gene.2011.10.018","volume":"492","author":"K Yamada","year":"2012","unstructured":"Yamada K, Nomura N, Yamano A, Yamada Y, Wakamatsu N. Identification and characterization of splicing variants of PLEKHA5 (Plekha5) during brain development. Gene. 2012;492(1):270\u20135. https:\/\/doi.org\/10.1016\/j.gene.2011.10.018.","journal-title":"Gene"},{"issue":"9","key":"2597_CR51","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1158\/1078-0432.CCR-14-0861","volume":"21","author":"LB Jilaveanu","year":"2015","unstructured":"Jilaveanu LB, Parisi F, Barr ML, et al. PLEKHA5 as a biomarker and potential mediator of melanoma brain metastasis. Clin Cancer Res. 2015;21(9):2138\u201347.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"2597_CR52","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/ng.2359","volume":"44","author":"M Krauthammer","year":"2012","unstructured":"Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, McCusker JP, Cheng E, Davis MJ, Goh G, Choi M, Ariyan S, Narayan D, Dutton-Regester K, Capatana A, Holman EC, Bosenberg M, Sznol M, Kluger HM, Brash DE, Stern DF, Materin MA, Lo RS, Mane S, Ma S, Kidd KK, Hayward NK, Lifton RP, Schlessinger J, Boggon TJ, Halaban R. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet. 2012;44(9):1006\u201314. https:\/\/doi.org\/10.1038\/ng.2359.","journal-title":"Nat Genet"},{"issue":"5","key":"2597_CR53","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/cncr.32611","volume":"126","author":"H Zhang","year":"2020","unstructured":"Zhang H, Zhu H, Deng G, et al. PLEKHA5 regulates tumor growth in metastatic melanoma. Cancer. 2020;126(5):1016\u201330.","journal-title":"Cancer"},{"issue":"3","key":"2597_CR54","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41389-021-00314-1","volume":"10","author":"Y Nagamura","year":"2021","unstructured":"Nagamura Y, Miyazaki M, Nagano Y, Yuki M, Fukami K, Yanagihara K, Sasaki K, Sakai R, Yamaguchi H. PLEKHA5 regulates the survival and peritoneal dissemination of diffuse-type gastric carcinoma cells with Met gene amplification. Oncogenesis. 2021;10(3):25. https:\/\/doi.org\/10.1038\/s41389-021-00314-1.","journal-title":"Oncogenesis"},{"issue":"4","key":"2597_CR55","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/cyto.b.21611","volume":"94","author":"E Reshetnikova","year":"2018","unstructured":"Reshetnikova E, Guselnikov S, Volkova O, Baranov K, Taranin A, Mechetina L. B cell-specific protein FCRLA is expressed by plasmacytoid dendritic cells in humans. Cytometry B Clin Cytom. 2018;94(4):683\u20137.","journal-title":"Cytometry B Clin Cytom"},{"issue":"2","key":"2597_CR56","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.imlet.2013.05.011","volume":"152","author":"S Kulemzin","year":"2013","unstructured":"Kulemzin S, Chikaev N, Volkova O, et al. Characterization of human FCRLA isoforms. Immunol Lett. 2013;152(2):153\u20138.","journal-title":"Immunol Lett"},{"issue":"12","key":"2597_CR57","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1038\/sj.jid.5700909","volume":"127","author":"T Inozume","year":"2007","unstructured":"Inozume T, Mitsui H, Okamoto T, et al. Dendritic cells transduced with autoantigen FCRLA induce cytotoxic lymphocytes and vaccinate against murine B-cell lymphoma. J Invest Dermatol. 2007;127(12):2818\u201322.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"2597_CR58","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1158\/0008-5472.CAN-08-1565","volume":"69","author":"B Li","year":"2009","unstructured":"Li B, Vincent A, Cates J, Brantley-Sieders DM, Polk DB, Young PP. Low levels of tumor necrosis factor alpha increase tumor growth by inducing an endothelial phenotype of monocytes recruited to the tumor site. Cancer Res. 2009;69(1):338\u201348.","journal-title":"Cancer Res"},{"key":"2597_CR59","first-page":"4181","volume":"63","author":"LB Nabors","year":"2003","unstructured":"Nabors LB, Suswam E, Huang Y, Yang X, Johnson MJ, King PH. Tumor necrosis factor alpha induces angiogenic factor up-regulation in malignant glioma cells: a role for RNA stabilization and HuR. Cancer Res. 2003;63:4181\u20137.","journal-title":"Cancer Res"},{"key":"2597_CR60","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/bs.acr.2016.05.005","volume":"132","author":"M Yao","year":"2016","unstructured":"Yao M, Brummer G, Acevedo D, Cheng N. Cytokine regulation of metastasis and tumorigenicity. Adv Cancer Res. 2016;132:265\u2013367.","journal-title":"Adv Cancer Res"},{"key":"2597_CR61","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1084\/jem.177.5.1391","volume":"177","author":"P Orosz","year":"1993","unstructured":"Orosz P, Echtenacher B, Falk W, R\u00fcschoff J, Weber D, M\u00e4nnel DN. Enhancement of experimental metastasis by tumor necrosis factor. J Exp Med. 1993;177:1391\u20138.","journal-title":"J Exp Med"},{"key":"2597_CR62","first-page":"3233","volume":"54","author":"H Okahara","year":"1994","unstructured":"Okahara H, Yagita H, Miyake K, Okumura K. Involvement of very late activation antigen 4 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) in tumor necrosis factor alpha enhancement of experimental metastasis. Cancer Res. 1994;54:3233\u20136.","journal-title":"Cancer Res"},{"key":"2597_CR63","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41392-022-01199-1","volume":"7","author":"X Zhou","year":"2022","unstructured":"Zhou X, Huang F, Ma G, Wei W, Wu N, Liu Z. Dysregulated ceramides metabolism by fatty acid 2-hydroxylase exposes a metabolic vulnerability to target cancer metastasis. Signal Transduct Target Ther. 2022;7:370.","journal-title":"Signal Transduct Target Ther"},{"key":"2597_CR64","doi-asserted-by":"publisher","first-page":"101055","DOI":"10.1016\/j.plipres.2020.101055","volume":"80","author":"KC Corn","year":"2020","unstructured":"Corn KC, Windham MA, Rafat M. Lipids in the tumor microenvironment: from cancer progression to treatment. Prog Lipid Res. 2020;80:101055.","journal-title":"Prog Lipid Res"},{"issue":"8","key":"2597_CR65","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1158\/0008-5472.CAN-15-2613","volume":"76","author":"OF Kuzu","year":"2016","unstructured":"Kuzu OF, Noory MA, Robertson GP. The role of cholesterol in Cancer. Cancer Res. 2016;76(8):2063\u201370.","journal-title":"Cancer Res"},{"issue":"1","key":"2597_CR66","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00262-015-1779-0","volume":"65","author":"L Raccosta","year":"2016","unstructured":"Raccosta L, Fontana R, Corna G, Maggioni D, Moresco M, Russo V. Cholesterol metabolites and tumor microenvironment: the road towards clinical translation. Cancer Immunol Immunother. 2016;65(1):111\u20137.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"2597_CR67","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","volume":"30","author":"X Ma","year":"2019","unstructured":"Ma X, Bi E, Lu Y, et al. Cholesterol induces CD8(+) T cell exhaustion in the tumor microenvironment. Cell Metab. 2019;30(1):143\u2013e1565.","journal-title":"Cell Metab"},{"issue":"1","key":"2597_CR68","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrc3398","volume":"13","author":"SA Morad","year":"2013","unstructured":"Morad SA, Cabot MC. Ceramide-orchestrated signalling in cancer cells. Nat Rev Cancer. 2013;13(1):51\u201365.","journal-title":"Nat Rev Cancer"},{"key":"2597_CR69","doi-asserted-by":"publisher","first-page":"101936","DOI":"10.1016\/j.molmet.2024.101936","volume":"83","author":"N Wajapeyee","year":"2024","unstructured":"Wajapeyee N, Beamon TC, Gupta R. Roles and therapeutic targeting of ceramide metabolism in cancer. Mol Metab. 2024;83:101936.","journal-title":"Mol Metab"},{"key":"2597_CR70","doi-asserted-by":"publisher","first-page":"111565","DOI":"10.1016\/j.biopha.2021.111565","volume":"139","author":"Z Li","year":"2021","unstructured":"Li Z, Zhang L, Liu D, Wang C. Ceramide glycosylation and related enzymes in cancer signaling and therapy. Biomed Pharmacother. 2021;139:111565.","journal-title":"Biomed Pharmacother"},{"key":"2597_CR71","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/s41556-024-01410-1","volume":"26","author":"M Granath-Panelo","year":"2024","unstructured":"Granath-Panelo M, Kajimura S. Mitochondrial heterogeneity and adaptations to cellular needs. Nat Cell Biol. 2024;26:674\u201386.","journal-title":"Nat Cell Biol"},{"key":"2597_CR72","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1476-4598-12-152","volume":"12","author":"S Ganapathy-Kanniappan","year":"2013","unstructured":"Ganapathy-Kanniappan S, Geschwind JF. Tumor Glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer. 2013;12:152.","journal-title":"Mol Cancer"},{"key":"2597_CR73","doi-asserted-by":"crossref","unstructured":"Nsiah-Sefaa A, McKenzie M. Combined defects in oxidative phosphorylation and fatty acid \u03b2-oxidation in mitochondrial disease. Biosci Rep. 2016;36:e00313.","DOI":"10.1042\/BSR20150295"},{"key":"2597_CR74","doi-asserted-by":"publisher","first-page":"151337","DOI":"10.1016\/j.ejcb.2023.151337","volume":"102","author":"J Alizadeh","year":"2023","unstructured":"Alizadeh J, da Silva Rosa SC, Weng X, Jacobs J, Lorzadeh S, Ravandi A, Vitorino R, Pecic S, Zivkovic A, Stark H, Shojaei S, Ghavami S. Ceramides and ceramide synthases in cancer: focus on apoptosis and autophagy. Eur J Cell Biol. 2023;102:151337.","journal-title":"Eur J Cell Biol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02597-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-025-02597-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02597-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T08:02:44Z","timestamp":1748937764000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-025-02597-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2597"],"URL":"https:\/\/doi.org\/10.1186\/s12944-025-02597-4","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethical committee of the Institute of Dermatology, Peking Union Medical College, Chinese Academy of Medical Sciences (Nanjing).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"198"}}